Abstract
Brazil is known for being a breeding ground for emerging infectious diseases (EIDs), such as Zika, dengue, and chikungunya. Given that it has been one of the countries most affected by the SARS-CoV-2 pandemic, this article aims to analyze the impact that the COVID-19 pandemic has had on the burden of infectious diseases in Brazil, especially that of dengue. Brazil is a unique territory with a heterogeneous population living in a tropical, wet climate favorable to infectious diseases. In addition, despite being one of the largest emerging economies in the world, the country has been exposed to political instability and a public health system that suffers from large funding shortfalls and a lack of coherent regulation. The findings from this study are multilayered. Firstly, as cases of COVID-19 rose at the start of the pandemic, cases of dengue declined drastically. This may be due, in part, to factors such as seasonal climate and distancing measures. Furthermore, the findings indicate that the diversion of resources away from dengue and other infectious diseases, and mobilization for COVID-19 testing and treatment, likely resulted in a serious underreporting of dengue. While Brazil has incorporated some of the lessons learned from past EID experience in responding to the COVID-19 pandemic, the analysis highlights how the country's structural problems present pitfalls in the epidemiological fight. It was concluded that in a country such as Brazil, where infectious disease outbreaks are only a matter of time, pandemic preparedness should be prioritized over pandemic response.
Highlights
Accepted: 17 February 2022The emergence of a new coronavirus, SARS-CoV-2, in 2019 led to a global pandemic of unprecedented scale and reach
The aim of this paper is to describe the current situation in Brazil and how the COVID-19 pandemic has impacted the trajectory of other infectious diseases in the country, dengue
This paper has provided a multifaceted description of Brazil and its previous experience with emerging infectious disease outbreaks
Summary
The emergence of a new coronavirus, SARS-CoV-2, in 2019 led to a global pandemic of unprecedented scale and reach. In the last decade, emerging infectious diseases (EIDs) have been increasingly recognized as a global threat, as evidenced by the development of pandemic preparedness concepts such as the World Health Organization’s Disease. No pathogen can be predicted before its appearance; the global community can take steps to note patterns in origin and spread and incorporate them into the design of disease surveillance programs [2]. While COVID-19 could not have been predicted exactly, Brazil’s uniquely high susceptibility to new disease outbreaks begs the question: How did Brazil’s experience preventing and controlling other EIDs shape its response to Published: 2 March 2022
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
